October 28, 2016 8:49 AM ET


Company Overview of Neogenix Oncology, Inc.

Company Overview

Neogenix Oncology, Inc., a clinical stage biotherapeutic company, focuses on developing novel therapeutic and diagnostic products for the treatment of pancreatic, colon, lung, prostate, and various other cancers. The company’s lead product candidate includes NEO-101 (Ensituximab), a novel Phase IIa monoclonal antibody for colorectal and pancreatic cancer indications. Its product pipeline also includes NEO-201 and NEO-301, which are preclinical monoclonal antibodies for the treatment of pancreatic and colorectal cancers. The company has a research collaboration agreement with San Raffaele-Pisana to study the expression of tumor-specific biomarkers using NEO-101, NEO-201, and NEO-301 therapeut...

445 Northern Boulevard

Suite 24

Great Neck, NY 11021

United States

Founded in 2003

14 Employees





Key Executives for Neogenix Oncology, Inc.

Chief Executive Officer, President, Chief Medical Officer and Director
Age: 52
Principal Founder
Age: 84
Chief Operating Officer
Age: 56
Director of Business Development
Chairman of Scientific Advisory Board and Chief Scientific Officer
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neogenix Oncology, Inc., please visit www.neogenix.us. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.